With fish oil pill US NDA submitted, Amarin could be acquisition target
This article was originally published in Scrip
Executive Summary
As promised, Amarin submitted its US new drug application (NDA) seeking approval to market its fish oil pill AMR101 as a treatment for patients with very high triglycerides – holding to its word to get the application filed this quarter.